vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and VINCE HOLDING CORP. (VNCE). Click either name above to swap in a different company.
VINCE HOLDING CORP. is the larger business by last-quarter revenue ($85.1M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 6.2%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-5.7M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 6.3%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
VINCE. is a contemporary clothing fashion brand founded in 2002. In 2023 Authentic Brands Group purchased its intellectual property in a $76.5 million deal.
PBYI vs VNCE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $85.1M |
| Net Profit | — | $2.7M |
| Gross Margin | 69.3% | 49.2% |
| Operating Margin | 22.7% | 6.4% |
| Net Margin | — | 3.2% |
| Revenue YoY | 27.7% | 6.2% |
| Net Profit YoY | — | -37.3% |
| EPS (diluted) | $0.26 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $85.1M | ||
| Q3 25 | $54.5M | $73.2M | ||
| Q2 25 | $52.4M | $57.9M | ||
| Q1 25 | $46.0M | $80.0M | ||
| Q4 24 | $59.1M | $80.2M | ||
| Q3 24 | $80.5M | $74.2M | ||
| Q2 24 | $47.1M | $59.2M | ||
| Q1 24 | $43.8M | $75.3M |
| Q4 25 | — | $2.7M | ||
| Q3 25 | $8.8M | $12.1M | ||
| Q2 25 | $5.9M | $-4.8M | ||
| Q1 25 | $3.0M | $-28.3M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | $20.3M | $569.0K | ||
| Q2 24 | $-4.5M | $4.4M | ||
| Q1 24 | $-4.8M | $-4.7M |
| Q4 25 | 69.3% | 49.2% | ||
| Q3 25 | 77.7% | 50.4% | ||
| Q2 25 | 76.5% | 50.3% | ||
| Q1 25 | 77.1% | 50.1% | ||
| Q4 24 | 76.4% | 50.0% | ||
| Q3 24 | 63.9% | 47.4% | ||
| Q2 24 | 77.4% | 50.6% | ||
| Q1 24 | 75.5% | 45.4% |
| Q4 25 | 22.7% | 6.4% | ||
| Q3 25 | 17.6% | 15.2% | ||
| Q2 25 | 12.7% | -7.7% | ||
| Q1 25 | 8.7% | -37.1% | ||
| Q4 24 | 22.6% | 7.2% | ||
| Q3 24 | 27.4% | 1.5% | ||
| Q2 24 | -4.6% | 9.5% | ||
| Q1 24 | -5.3% | -2.2% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | 16.2% | 16.5% | ||
| Q2 25 | 11.2% | -8.3% | ||
| Q1 25 | 6.5% | -35.5% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | 25.2% | 0.8% | ||
| Q2 24 | -9.6% | 7.4% | ||
| Q1 24 | -11.0% | -6.2% |
| Q4 25 | $0.26 | $0.21 | ||
| Q3 25 | $0.17 | $0.93 | ||
| Q2 25 | $0.12 | $-0.37 | ||
| Q1 25 | $0.06 | $-2.25 | ||
| Q4 24 | $0.40 | $0.34 | ||
| Q3 24 | $0.41 | $0.05 | ||
| Q2 24 | $-0.09 | $0.35 | ||
| Q1 24 | $-0.10 | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $1.1M |
| Total DebtLower is stronger | $22.7M | — |
| Stockholders' EquityBook value | $130.3M | $53.4M |
| Total Assets | $216.3M | $246.0M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $1.1M | ||
| Q3 25 | $94.4M | $777.0K | ||
| Q2 25 | $96.0M | $2.6M | ||
| Q1 25 | $93.2M | $607.0K | ||
| Q4 24 | $101.0M | $892.0K | ||
| Q3 24 | $96.7M | $711.0K | ||
| Q2 24 | $96.8M | $739.0K | ||
| Q1 24 | $107.2M | $357.0K |
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
| Q4 25 | $130.3M | $53.4M | ||
| Q3 25 | $115.3M | $49.3M | ||
| Q2 25 | $104.7M | $37.2M | ||
| Q1 25 | $97.1M | $41.8M | ||
| Q4 24 | $92.1M | $57.1M | ||
| Q3 24 | $71.1M | $52.4M | ||
| Q2 24 | $48.5M | $51.7M | ||
| Q1 24 | $51.0M | $47.2M |
| Q4 25 | $216.3M | $246.0M | ||
| Q3 25 | $202.9M | $239.0M | ||
| Q2 25 | $194.9M | $218.0M | ||
| Q1 25 | $196.2M | $222.7M | ||
| Q4 24 | $213.3M | $254.7M | ||
| Q3 24 | $220.7M | $253.6M | ||
| Q2 24 | $205.0M | $223.1M | ||
| Q1 24 | $214.1M | $225.1M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $-5.1M |
| Free Cash FlowOCF − Capex | $14.4M | $-5.7M |
| FCF MarginFCF / Revenue | 19.1% | -6.7% |
| Capex IntensityCapex / Revenue | 0.0% | 0.7% |
| Cash ConversionOCF / Net Profit | — | -1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $-5.1M | ||
| Q3 25 | $9.7M | $4.2M | ||
| Q2 25 | $14.1M | $-11.8M | ||
| Q1 25 | $3.6M | $22.7M | ||
| Q4 24 | $15.6M | $6.4M | ||
| Q3 24 | $11.0M | $-3.2M | ||
| Q2 24 | $1.0M | $-3.9M | ||
| Q1 24 | $11.2M | $14.8M |
| Q4 25 | $14.4M | $-5.7M | ||
| Q3 25 | $9.7M | $2.1M | ||
| Q2 25 | $14.1M | $-13.2M | ||
| Q1 25 | $3.6M | $21.2M | ||
| Q4 24 | $15.6M | $5.1M | ||
| Q3 24 | $11.0M | $-3.9M | ||
| Q2 24 | $1.0M | $-4.6M | ||
| Q1 24 | — | $14.2M |
| Q4 25 | 19.1% | -6.7% | ||
| Q3 25 | 17.7% | 2.9% | ||
| Q2 25 | 26.8% | -22.9% | ||
| Q1 25 | 7.7% | 26.5% | ||
| Q4 24 | 26.4% | 6.4% | ||
| Q3 24 | 13.7% | -5.2% | ||
| Q2 24 | 2.1% | -7.8% | ||
| Q1 24 | — | 18.9% |
| Q4 25 | 0.0% | 0.7% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.1% | 1.9% | ||
| Q4 24 | 0.0% | 1.6% | ||
| Q3 24 | 0.0% | 0.9% | ||
| Q2 24 | 0.0% | 1.3% | ||
| Q1 24 | 0.0% | 0.7% |
| Q4 25 | — | -1.86× | ||
| Q3 25 | 1.10× | 0.35× | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | 0.54× | -5.61× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
VNCE
| Vince Wholesale | $52.0M | 61% |
| Vince Direct To Consumer | $33.1M | 39% |
